Go to main content
 
DH endorses recall of tablet for relief of allergic symptoms (with photo)
*************************************************************************
     The Department of Health (DH) today (December 1) endorsed a licensed drug wholesaler, Kai Yuen Pharmaceutical Company (Kai Yuen), to recall a batch (Lot No./ Mfg. Lot No.: C18) of Finska Tablet 10mg (registration number HK-57988) from the market due to quality issue.

     During the DH's market surveillance, samples of the above product were collected for analysis and examination. Upon testing by the Public Health Laboratory Services Branch of the Centre for Health Protection, samples of the product were found to have exceeded the pharmacopoeial requirements on bacterial counts. Kai Yuen voluntarily recalls the above batch from the market. The DH's investigation is continuing.

     Finska Tablet 10mg contains loratadine, which is a Part 1 poison under the Pharmacy and Poisons Ordinance (Cap 138) and is used for the relief of allergic symptoms. According to the wholesaler, the affected batch has been supplied to private doctors, local pharmacies and other wholesaler.

     "So far, the DH has not received any adverse drug reaction reports in connection with the product. We will closely monitor the recall," a spokesman for the DH said.

     "Members of the public should consult healthcare professionals if in doubt or feeling unwell after using the product," the spokesman added.

     Kai Yuen has set up a hotline (2395 5763) to answer related enquiries.
 
Ends/Friday, December 1, 2017
Issued at HKT 21:08
NNNN
Today's Press Releases  

Photo

The Department of Health today (December 1) endorsed a licensed drug wholesaler, Kai Yuen Pharmaceutical Company, to recall a batch of Finska Tablet 10mg from the market due to quality issue.